inflammatix.com
Open in
urlscan Pro
198.71.233.231
Public Scan
Submitted URL: http://inflammatix.com/
Effective URL: https://inflammatix.com/
Submission: On September 02 via api from US — Scanned from DE
Effective URL: https://inflammatix.com/
Submission: On September 02 via api from US — Scanned from DE
Form analysis
1 forms found in the DOMGET https://inflammatix.com/
<form role="search" class="searchform fusion-search-form fusion-live-search fusion-search-form-classic" method="get" action="https://inflammatix.com/">
<div class="fusion-search-form-content">
<div class="fusion-search-field search-field">
<label><span class="screen-reader-text">Search for:</span>
<input type="search" class="s fusion-live-search-input" name="s" id="fusion-live-search-input-0" autocomplete="off" placeholder="Search..." required="" aria-required="true" aria-label="Search...">
</label>
</div>
<div class="fusion-search-button search-button">
<input type="submit" class="fusion-search-submit searchsubmit" aria-label="Search" value="" data-color="rgb(255, 255, 255)">
<div class="fusion-slider-loading"></div>
</div>
</div>
<div class="fusion-search-results-wrapper">
<div class="fusion-search-results"></div>
</div>
</form>
Text Content
Product in development, is not for sale, and does not have marketing approval or clearance from regulatory authorities in any jurisdiction. of acute infections PRESENCE TYPE SEVERITY Quickly identifies the TriVerity™ Product in development, is not for sale, and does not have marketing approval or clearance from regulatory authorities in any jurisdiction. BACTERIAL or VIRAL Quickly identifies infections as BacVerity™ Skip to content * Pipeline * TriVerity * BacVerity * Our Approach * In Development * Education * Inflammatix Topix * Inflammatix Didactix * Advocacy * Evidence * Publications * Abstracts * Groundbreaking Science * Machine Learning * News * Press Releases * Inflammatix in the News * Media Contact * Logos * Events * Careers * About * Our Mission * Leadership * Investors * Partner With Us * Awards * Contact Us * Ask a Question * Search for: * Pipeline * TriVerity * BacVerity * Our Approach * In Development * Education * Inflammatix Topix * Inflammatix Didactix * Advocacy * Evidence * Publications * Abstracts * Groundbreaking Science * Machine Learning * News * Press Releases * Inflammatix in the News * Media Contact * Logos * Events * Careers * About * Our Mission * Leadership * Investors * Partner With Us * Awards * Contact Us * Ask a Question We’re reimagining diagnostics by READING THE IMMUNE SYSTEM Inflammatix – Homebiosearchadmin2022-08-12T14:32:30-07:00 We’re reimagining diagnostics by READING THE IMMUNE SYSTEM HOST RESPONSE DIAGNOSTICS Delivering precision medicine on demand ACTIONABLE RESULTS We rapidly measure the patient’s immune response using proprietary algorithms to generate clinically actionable results in less than 30 minutes. Faster diagnosis means smarter antibiotics prescribing and level of care decisions, which enables better patient outcomes. CLINICALLY VALIDATED Validated in numerous independent cohorts involving thousands of patients and published in leading medical journals, Inflammatix is your trusted partner for providing state-of-the-art diagnostic solutions. SEE OUR PIPELINE Product in development, is not for sale, and does not have marketing approval or clearance from regulatory authorities in any jurisdiction. ACUTE INFECTION & SEPSIS TEST FOR HOSPITALS Determine the presence, type and severity of infection to make smarter antibiotic prescribing and admission decisions. Learn More Product in development, is not for sale, and does not have marketing approval or clearance from regulatory authorities in any jurisdiction. ACUTE INFECTION TEST FOR CLINICS Quickly determine whether infections are likely viral or bacterial to empower appropriate antibiotic usage. Learn More Product in development, is not for sale, and does not have marketing approval or clearance from regulatory authorities in any jurisdiction. Our tests are addressing significant clinical needs in acute infection and sepsis diagnosis that affect millions of people Products in development, not for sale, and do not have marketing approval or clearance from regulatory authorities in any jurisdiction. IN THE NEWS Recent notable news stories Do Your Genes Know What’s Making You Sick? January 6, 2022 Artificial Intelligence for Clinical Decision Support in Sepsis May 13, 2021 Inflammatix Checks off All the Right Boxes with Investors March 19, 2021 Inflammatix nets $102M to advance its immune system tests for infectious diseases March 16, 2021 Also covered by * * * * * * * * * * * * * * * * * * * * * * * SEE ALL NEWS Stay in touch with social updates: Find out the latest news. Follow us on Twitter Follow us on LinkedIn Inflammatix is reimagining diagnostics by developing rapid tests that read the immune system to resolve major clinical and public health challenges. Our initial focus is on acute bacterial and viral infections, and sepsis. We’re seeking teammates with expertise, curiosity and passion for solving clinical challenges with a focus on patient outcomes. If that sounds like you, check out our Careers Page. © Copyright 2022, Inflammatix, Inc. All Rights Reserved | Terms & Conditions | Privacy & Cookies Statement Products in development, are not for sale, and do not have marketing approval or clearance from regulatory authorities in any jurisdiction. LinkedInTwitter Page load link Go to Top Cookies Button COOKIE SETTINGS By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Privacy & Cookies Statement Accept All Cookies Reject All Cookies Settings